Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Which shoulder treatment helps you sleep better? new study aims to find out

NCT ID NCT06631976

Symptom relief Sponsor: Medical University of Lodz Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares four non-surgical treatments for a common shoulder tendon injury (supraspinatus tear) that causes pain and sleep problems. The treatments include a steroid injection, a nerve block, platelet-rich plasma (PRP), and rehabilitation. Researchers will track pain, shoulder function, and sleep quality over six months in 40 adults aged 40-75. The goal is to find which approach works best and fastest.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
methylprednisolone acetate, lidocaine, platelet-rich plasma (PRP)
What this could lead to
If successful, this could identify the best non-surgical treatment to relieve shoulder pain and improve sleep quality for people with rotator cuff injuries.
What could go wrong
This is a small, early-stage study with only 40 participants, so results may not apply to everyone. The treatments are well-known, but individual responses can vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 40 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2024

Expected to finish

Sep 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

40 to 75 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Symptomatic partial incomplete thickness tear of the supraspinatus tendon, with a length below 1 cm and not exceeding 50% of the tendon thickness, confirmed by ultrasound examination. 2. Sleep disturbance symptoms for at least 1 month due to shoulder pain - PSQI score \> 5. 3. Shoulder pain disrupting the quality of sleep. 4. BMI \< 30. 5. Age 40-75. Exclusion Criteria: 1. Other accompanying pain symptoms. 2. History of shoulder surgery. 3. Coexistence of psychiatric or neurological disorders. 4. Presence of comorbidities that may disrupt sleep. 5. Presence of risk factors impairing tissue regeneration and increasing the likelihood of injury progression - osteoporosis, diabetes, hypercholesterolemia. 6. Alcohol dependence, nicotine addiction, passive smoking. 7. Taking antibiotics from the fluoroquinolone group, sleep-affecting medications (such as melatonin, trazodone, zolpidem), antidepressants, antipsychotics, anxiolytics. 8. Lack of patient consent, lack of cooperation, or impaired verbal-logical communication.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Sleep disturbance are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Parasomnias rotator cuff syndrome sleep disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Sleep disturbance Supraspinatus injury

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Medical University of Lodz

    RECRUITING

    Lodz, Łódź Voivodeship, 90-419, Poland

More trials for these conditions

Other studies related to the condition(s) this trial covers.